Truist lowered the firm’s price target on AdaptHealth (AHCO) to $12 from $13 and keeps a Buy rating on the shares. The firm is adjusting its model after the company’s Q3 results and updated FY24 guidance, the analyst tells investors in a research note. Truist is cutting its FY24 EPS view on AdaptHealth by 6c to 93c and its FY25 view by 15c to $1.04.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio